Abstract
Background/Objectives
The role of vitamin E in chronic disease risk remains incompletely understood, particularly in an un-supplemented state, and evidence is sparse regarding the biological actions and pathways involved in its influence on health outcomes. Identifying vitamin-E-associated metabolites through agnostic metabolomics analyses can contribute to elucidating the specific associations and disease etiology. This study aims to investigate the association between circulating metabolites and serum α-tocopherol concentration in an un-supplemented state.
Subjects/Methods
Metabolomic analysis of 4,294 male participants was conducted based on pre-supplementation fasting serum in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. The associations between 1,791 known metabolites measured by ultra-high-performance LC–MS/GC–MS and HPLC-determined α-tocopherol concentration were estimated using multivariable linear regression. Differences in metabolite levels per unit difference in α-tocopherol concentration were calculated as standardized β-coefficients and standard errors.
Results
A total of 252 metabolites were associated with serum α-tocopherol at the Bonferroni-corrected p value (p < 2.79 × 10−5). Most of these metabolites were of lipid and amino acid origin, with the respective subclasses of dicarboxylic fatty acids, and valine, leucine, and isoleucine metabolism, being highly represented. Among lipids, the strongest signals were observed for linoleoyl-arachidonoyl-glycerol (18:2/20:4)[2](β = 0.149; p = 8.65 × 10−146) and sphingomyelin (D18:2/18:1) (β = 0.035; p = 1.36 × 10−30). For amino acids, the strongest signals were aminoadipic acid (β = 0.021; p = 5.01 × 10−13) and l-leucine (β = 0.007; p = 1.05 × 10−12).
Conclusions
The large number of metabolites, particularly lipid and amino acid compounds associated with serum α-tocopherol provide leads regarding potential mechanisms through which vitamin E influences human health, including its role in cardiovascular disease and cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Code availability
The analytical methods for this study are available from the corresponding author upon appropriate request.
References
Jiang Q, Christen S, Shigenaga MK, Ames BN. γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001;74:714–22.
Traber MG. Vitamin E regulatory mechanisms. Annu Rev Nutr. 2007;27:347–62.
Jiang Q. Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med. 2014;72:76–90.
Ju J, Picinich SC, Yang Z, Zhao Y, Suh N, Kong A-N, et al. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis. 2010;31:533–42.
Huang J, Weinstein SJ, Yu K, Männistö S, Albanes D. A prospective study of serum vitamin e and 28-year risk of lung cancer. JNCI J Natl Cancer Inst. 2020;112:191–9.
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39–51.
Virtamo J, Taylor PR, Kontto J, Männistö S, Utriainen M, Weinstein SJ, et al. Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Int J cancer. 2014;135:178–85.
Cheng P, Wang L, Ning S, Liu Z, Lin H, Chen S, et al. Vitamin E intake and risk of stroke: a meta-analysis. Br J Nutr. 2018;120:1181–8.
Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, et al. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. Am J Clin Nutr. 2018;108:1069–91.
Schwingshackl L, Boeing H, Stelmach-Mardas M, Gottschald M, Dietrich S, Hoffmann G, et al. Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials. Adv Nutr Int Rev J. 2017;8:27–39.
Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet. 2003;361:2017–23.
The ATBC cancer prevention study group. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol. 1994;4:1–10.
Mondul AM, Moore SC, Weinstein SJ, Karoly ED, Sampson JN, Albanes D. Metabolomic analysis of prostate cancer risk in a prospective cohort: the alpha‐tocopherol, beta‐carotene cancer prevention (ATBC) study. Int J Cancer. 2015;137:2124–32.
Mondul AM, Sampson JN, Moore SC, Weinstein SJ, Evans AM, Karoly ED, et al. Metabolomic profile of response to supplementation with β-carotene in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr. 2013;98:488–93.
Mondul AM, Moore SC, Weinstein SJ, Männistö S, Sampson JN, Albanes D. 1-Stearoylglycerol is associated with risk of prostate cancer: results from a serum metabolomic profiling analysis. Metabolomics. 2014;10:1036–41.
Mondul AM, Moore SC, Weinstein SJ, Evans AM, Karoly ED, Männistö S, et al. Serum metabolomic response to long-term supplementation with all-rac-α-tocopheryl acetate in a randomized controlled trial. J Nutr Metab. 2016;2016:6158436.
Huang J, Weinstein SJ, Kitahara CM, Karoly ED, Sampson JN, Albanes D. A prospective study of serum metabolites and glioma risk. Oncotarget. 2017;8:70366–77.
Huang J, Mondul AM, Weinstein SJ, Karoly ED, Sampson JN, Albanes D. Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor. Oncotarget. 2017;8:45190–9.
Huang J, Mondul AM, Weinstein SJ, Derkach A, Moore SC, Sampson JN, et al. Prospective serum metabolomic profiling of lethal prostate cancer. Int J cancer. 2019;145:3231–43.
Stolzenberg-Solomon R, Derkach A, Moore S, Weinstein SJ, Albanes D, Sampson J. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study. Gut. 2020;69:2008–15.
Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81:6656–67.
Dehaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform. 2010;2:9.
Nelson SM, Panagiotou OA, Anic GM, Mondul AM, Männistö S, Weinstein SJ, et al. Metabolomics analysis of serum 25-hydroxy-vitamin D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Int J Epidemiol. 2016;45:1458–68.
Efron B, Tibshirani R. On testing the significance of sets of genes. Ann Appl Stat. 2007;1:107–29.
Wang TJ, Ngo D, Psychogios N, Dejam A, Larson MG, Vasan RS, et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest. 2013;123:4309–17.
Huang J, Mondul AM, Weinstein SJ, Koutros S, Derkach A, Karoly E, et al. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Br J Cancer. 2016;115:1087–95.
Cross AJ, Major JM, Sinha R. Urinary biomarkers of meat consumption. Cancer Epidemiol Biomark Prev. 2011;20:1107–11.
Elliott P, Posma JM, Chan Q, Garcia-Perez I, Wijeyesekera A, Bictash M, et al. Urinary metabolic signatures of human adiposity. Sci Transl Med. 2015;7:285ra62.
Wang K, Zelnick LR, Hoofnagle AN, Chen Y, de Boer IH, Himmelfarb J, et al. Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease. Nephrol Dial Transpl. 2020;35:1916–23.
Chen Y, Zelnick LR, Wang K, Hoofnagle AN, Becker JO, Hsu C, et al. Kidney clearance of secretory solutes is associated with progression of CKD: The CRIC Study. J Am Soc Nephrol. 2020;31:817–27.
Lécuyer L, Dalle C, Micheau P, Pétéra M, Centeno D, Lyan B, et al. Untargeted plasma metabolomic profiles associated with overall diet in women from the SU.VI.MAX cohort. Eur J Nutr. 2020;59:3425–39.
Abdulla KA, Um CY, Gross MD, Bostick RM. Circulating γ-tocopherol concentrations are inversely associated with antioxidant exposures and directly associated with systemic oxidative stress and inflammation in adults. J Nutr. 2018;148:1453–61.
Galli F, Azzi A, Birringer M, Cook-Mills JM, Eggersdorfer M, Frank J, et al. Vitamin E: Emerging aspects and new directions. Free Radic Biol Med. 2017;102:16–36.
Turrini E, Sestili P, Fimognari C. Overview of the anticancer potential of the “king of spices” piper nigrum and its main constituent piperine. Toxins (Basel). 2020;12:747.
Pastor RF, Repetto MG, Lairion F, Lazarowski A, Merelli A, Manfredi Carabetti Z, et al. Supplementation with resveratrol, piperine and alpha-tocopherol decreases chronic inflammation in a cluster of older adults with metabolic syndrome. Nutrients. 2020;12:3149.
Feng B, Guo Z, Zhang W, Pan Y, Zhao Y. Metabolome response to temperature-induced virulence gene expression in two genotypes of pathogenic Vibrio parahaemolyticus. BMC Microbiol. 2016;16:75.
Wright ME, Bowen P, Virtamo J, Albanes D, Gann PH. Estimated phytanic acid intake and prostate cancer risk: a prospective cohort study. Int J Cancer. 2012;131:1396–406.
Kamal-Eldin A, Appelqvist L-Å. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids. 1996;31:671–701.
Perng W, Rifas‐Shiman SL, Sordillo J, Hivert M, Oken E. Metabolomic profiles of overweight/obesity phenotypes during adolescence: a cross‐sectional study in project viva. Obesity. 2020;28:379–87.
Preuss C, Jelenik T, Bódis K, Müssig K, Burkart V, Szendroedi J, et al. A new targeted lipidomics approach reveals lipid droplets in liver, muscle and heart as a repository for diacylglycerol and ceramide species in non-alcoholic fatty liver. Cells. 2019;8:277.
Carrasco S, Mérida I. Diacylglycerol, when simplicity becomes complex. Trends Biochem Sci. 2007;32:27–36.
Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature. 2014;510:58–67.
Norris GH, Blesso CN. Dietary and endogenous sphingolipid metabolism in chronic inflammation. Nutrients. 2017;9:1180.
Turpin-Nolan SM, Brüning JC. The role of ceramides in metabolic disorders: when size and localization matters. Nat Rev Endocrinol. 2020;16:224–33.
Cross AJ, Moore SC, Boca S, Huang W-Y, Xiong X, Stolzenberg-Solomon R, et al. A prospective study of serum metabolites and colorectal cancer risk. Cancer. 2014;120:3049–57.
Loftfield E, Rothwell JA, Sinha R, Keski-Rahkonen P, Robinot N, Albanes D, et al. Prospective investigation of serum metabolites, coffee drinking, liver cancer incidence, and liver disease mortality. JNCI J Natl Cancer Inst. 2020;112:286–94.
Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, et al. -Tocopherol and beta-Carotene Supplements and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of Base-line Characteristics and Study Compliance. JNCI J Natl Cancer Inst. 1996;88:1560–70.
Wu Q-J, Xiang Y-B, Yang G, Li H-L, Lan Q, Gao Y-T, et al. Vitamin E intake and the lung cancer risk among female nonsmokers: a report from the Shanghai Women’s Health Study. Int J cancer. 2015;136:610–7.
Huang J, Weinstein SJ, Yu K, Männistö S, Albanes D. Relationship between serum alpha-tocopherol and overall and cause-specific mortality. Circ Res. 2019;125:29–40.
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JMO, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer. JAMA. 2005;293:1338.
Acknowledgements
We appreciate the participants in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study for their contributions to this research.
Funding
This research was supported by the Intramural Research Program of the US National Institutes of Health (NIH) National Cancer Institute.
Author information
Authors and Affiliations
Contributions
Conception and design: WRL, JNS, DA. Development of methodology: WRL, JH, JNS, DA. Acquisition of data WRL, SJW, DA. Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): WL, JL, JH, SJW, JNS, DA. Writing, review, and/or revision of the manuscript: WRL, JL, JH, JNS, SJW, DA.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Lawrence, W.R., Lim, JE., Huang, J. et al. Metabolomic analysis of serum alpha-tocopherol among men in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. Eur J Clin Nutr 76, 1254–1265 (2022). https://doi.org/10.1038/s41430-022-01112-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-022-01112-7
This article is cited by
-
Association between dietary vitamin E intake and cognitive decline among old American: National Health and Nutrition Examination Survey
European Geriatric Medicine (2023)
-
An integrated multi-omics analysis of sleep-disordered breathing traits implicates P2XR4 purinergic signaling
Communications Biology (2023)